TITLE

Bayesian analysis for medical device trials

PUB. DATE
August 2005
SOURCE
American Journal of Gastroenterology;Aug2005, Vol. 100 Issue 8, p1732
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
21952683

 

Related Articles

  • Bayesian guidance no game-breaker.  // Medical Device Daily;2/8/2010, Vol. 14 Issue 25, p8 

    This article deals with the final guidance issued by the U.S. Food and Drug Administration regarding the use of trials designed around Bayesian statistical analysis for medical devices and diagnostics.

  • Medical device innovation initiative.  // WHO Drug Information;2006, Vol. 20 Issue 2, p87 

    The article reports on the establishment of the Medical Device Innovation Initiative by the U.S. Food and Drug Adminstration (FDA) to promote early interaction between the agency and industries to achieve maximum efficiency and foster scientific innovations of medical devices. New guidelines...

  • Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis. Berry, Donald A. // Clinical Trials;2005, Vol. 2 Issue 4, p295 

    The Bayesian approach and several of its advantages in drug and medical device development are described. One advantage from the perspective of analysis is that it provides a methodology for synthesizing information. However, taking a Bayesian approach to designing clinical trials is potentially...

  • The experience in the FDA's Center for Devices and Radiological Health with Bayesian strategies. Campbell, Gregory // Clinical Trials;2005, Vol. 2 Issue 4, p359 

    Presents information on the process through which Bayesian statistics might be brought to bear in the premarket evaluation of medical devices within the U.S. Food and Drug Administration. Bayesian methods and ethics in a clinical trial design; Information on areas of Bayesian application in...

  • FDA Bayesian Statistics Guidance for Medical Device Clinical Trials--Application to Process Validation. LeBlond, David // Journal of Validation Technology;Autumn2010, Vol. 16 Issue 4, p24 

    The article offers an overview of the document, titled "Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials," which was issued by the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health and Center for Biologics Evaluation and Research....

  • Bayesian seen as ready for prime time as it can ever be. McCARTY, MARK // Medical Device Daily;9/28/2009, Vol. 13 Issue 186, p1 

    The article discusses the issues concerning Bayesian statistical analysis tackled at the 2009 Transcatheter Cardiovascular Therapeutics. A session at the event discussed how Bayesian and frequentist approaches can be applied to clinical trial designs. The views of John Boscardin, assistant...

  • Practice and Guidance for Conducting Bayesian Interim Analyses in Clinical Trials. Li, Hal; Gates, Davis // Proceedings of the World Congress on Engineering & Computer Scie;2013, p1 

    The theory and methods for the Bayesian Interim Analysis for Clinical Trials are motivators for this presentation. Introductions to the Bayesian statistics, Bayesian Inference, and interim analysis for clinical trials are provided, along with detailed discussion of the theory. Practical examples...

  • Using Adaptive Trial Design to Get Ahead of Tougher Regulations. Spiess, Laurent; Zippel, Erdmann // Medical Product Outsourcing;May2014, Vol. 12 Issue 4, p86 

    The article focuses on the implementation of adaptive trial design, and risk monitoring strategies to meet the requirements in updating the medical device regulations in the European Commission. It mentions that the strategies has the potential to lessen costs, and time delays in the company. It...

  • Bayesian statistics: how to quantify uncertainty. Mcculloch, T. J. // Anaesthesia & Intensive Care;Nov2011, Vol. 39 Issue 6, p1001 

    The author reflects on quantifying doubt in Bayesian statistics. He mentions that the assurance that a hypothesis is real cannot be based on one trial but account all the information available from outside the trial. He states that it is unlikely Bayesian analysis will substitute the referring...

  • Device Center Enthusiastic About Bayesian Trial Submissions.  // Medical Design Technology;Aug2006, Vol. 10 Issue 8, p10 

    The article reports that United States Food and Drug Administration Center for Devices and Radiological Health(CDRH) devote much of its time and effort analyzing Bayesian medical device trials. Agency director, Greg Campbell states that CDRH statisticians focus on the statistical technique for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics